Raub Brock Capital Management LP Abb Vie Inc. Transaction History

Raub Brock Capital Management LP

$479 Million
Q3 2024

A detailed history of Raub Brock Capital Management LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Raub Brock Capital Management LP holds 102,423 shares of ABBV stock, worth $18.4 Million. This represents 4.22% of its overall portfolio holdings.

Number of Shares

102,423

Previous 104,729 2.2%

Holding current value

$18.4 Million

Previous $18 Million 12.6%

% of portfolio

4.22%

Previous 4.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$163.84 - $199.33 $377,815 - $459,654	-2,306 Reduced 2.2%	102,423 $20.2 Million
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $240,698 - $281,081	-1,555 Reduced 1.46%	104,729 $18 Million
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $1.06 Million - $1.21 Million	-6,624 Reduced 5.87%	106,284 $19.4 Million
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $3.56 Million - $4.01 Million	-25,870 Reduced 18.64%	112,908 $17.5 Million
Q3 2023 Oct 12, 2023	SELL	$133.59 - $154.65 $546,650 - $632,827	-4,092 Reduced 2.86%	138,778 $20.7 Million
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $233,747 - $290,883	-1,764 Reduced 1.22%	142,870 $19.2 Million
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $423,418 - $487,629	2,928 Added 2.07%	144,634 $23.1 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $2.49 Million - $2.98 Million	-17,979 Reduced 11.26%	141,706 $22.9 Million
Q3 2022 Oct 13, 2022	SELL	$134.21 - $153.93 $2.88 Million - $3.3 Million	-21,442 Reduced 11.84%	159,685 $21.4 Million
Q2 2022 Jul 07, 2022	SELL	$137.62 - $174.96 $3.7 Million - $4.7 Million	-26,888 Reduced 12.93%	181,127 $27.7 Million
Q1 2022 Apr 13, 2022	SELL	$131.98 - $163.75 $5.23 Million - $6.49 Million	-39,654 Reduced 16.01%	208,015 $33.7 Million
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $280,576 - $318,496	-2,637 Reduced 1.05%	247,669 $26.7 Million
Q2 2021 Jul 21, 2021	SELL	$105.21 - $117.21 $639,887 - $712,871	-6,082 Reduced 2.37%	250,306 $28.2 Million
Q1 2021 Apr 16, 2021	SELL	$102.3 - $112.62 $700,755 - $771,447	-6,850 Reduced 2.6%	256,388 $27.7 Million
Q4 2020 Jan 06, 2021	SELL	$80.49 - $108.67 $478,110 - $645,499	-5,940 Reduced 2.21%	263,238 $28.2 Million
Q3 2020 Oct 23, 2020	SELL	$85.91 - $100.83 $143,727 - $168,688	-1,673 Reduced 0.62%	269,178 $23.6 Million
Q2 2020 Jul 14, 2020	SELL	$73.37 - $98.18 $1.18 Million - $1.58 Million	-16,057 Reduced 5.6%	270,851 $26.6 Million
Q1 2020 Apr 21, 2020	SELL	$64.5 - $97.79 $597,399 - $905,730	-9,262 Reduced 3.13%	286,908 $21.9 Million
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $21.4 Million - $26.7 Million	296,170 New	296,170 $26.2 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raub Brock Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Raub Brock Capital Management LP with notifications on news.

Account

Raub Brock Capital Management LP Abb Vie Inc. Transaction History